Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Operating Expenses | 19,727 | 16,672 | 15,345 | 17,864 | 14,330 |
| Operating Income | -19,727 | -16,672 | -15,345 | -17,864 | -14,330 |
| Interest Expense | 998 | 1,082 | 1,102 | 1,072 | 952 |
| Other Income | 8,696 | 8,461 | -13,822 | 26,342 | -16,296 |
| Pre-tax Income | -12,029 | -9,293 | -30,269 | 7,406 | -31,578 |
| Net Income Continuous | -12,029 | -9,293 | -30,269 | 7,406 | -31,578 |
| Net Income | $-12,029 | $-9,293 | $-30,269 | $7,406 | $-31,578 |
| EPS Basic Total Ops | -0.24 | 0.05 | -0.63 | 0.19 | -1.16 |
| EPS Basic Continuous Ops | -0.24 | 0.05 | -0.63 | 0.19 | -1.16 |
| EPS Diluted Total Ops | -0.24 | 0.50 | -0.63 | -0.26 | -1.16 |
| EPS Diluted Continuous Ops | -0.24 | 0.09 | -0.63 | 0.14 | -1.16 |
| EPS Diluted Before Non-Recurring Items | -0.24 | -0.24 | -0.31 | N/A | N/A |
| EBITDA(a) | $-18,912 | $-15,896 | $-14,623 | $-17,179 | $-13,606 |